2m 2m 2m 2m 2m 2m 2m
HCW BIOLOGICS (HCWB)
NASDAQ
$1.70-$0.09 (-5.31%)
Price as of Jun 03, 2026 6:45 PM EDT- $14.2MMarket Cap
- -73.28%1-Year Change
- BiotechnologyIndustry
HCW BIOLOGICS (HCWB)
$1.70-$0.09 (-5.31%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 16.2M +531.14% | 2.6M -9.68% | 2.8M -57.72% | 6.7M +63.95% | |
Cost of Revenue | 43,386 -97.30% | 1.6M -29.54% | 2.3M -44.84% | 4.1M N/A | |
Gross Profit | 10,846 -98.87% | 959,403 +71.21% | 560,360 -78.33% | 2.6M -36.92% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -5.4M -14.81% | -6.4M -16.77% | -7.7M -17.80% | -9.3M +14.25% | |
Depreciation and Amortization Expense | 1.0M -12.04% | 1.2M +4.33% | 1.1M +58.14% | 717,854 +32.06% | |
Total Operating Expenses | 13.2M -56.72% | 30.4M +15.84% | 26.3M +48.75% | 17.7M +32.15% | |
Operating Profit | -13.2M -55.35% | -29.5M +14.63% | -25.7M +70.55% | -15.1M +12.80% | |
Interest Income | -273,422 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -845,051 +33.89% | -631,137 +122.98% | -283,042 +123.47% | -126,660 N/A | |
Interest Income and Expense and Net | -1.1M +77.22% | -631,137 +122.98% | -283,042 +123.47% | -126,660 -125.06% | |
Total Nonoperating Income and Expense | 0 -100.00% | 631,137 +122.98% | 283,042 +123.47% | 126,660 N/A | |
Income before Taxes | -22.3M -24.36% | -29.5M +14.63% | -25.7M +70.55% | -15.1M +17.23% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | 5.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -8.0M -73.49% | -30.0M +20.12% | -25.0M +67.74% | -14.9M +15.85% | |
Net Income from Continuing Operations Applicable to Common | -22.3M -25.73% | -30.0M +20.12% | -25.0M +67.74% | -14.9M +15.85% | |
Basic EPS and Net Income | -10.63 +1,280.52% | -0.77 +10.00% | -0.70 +66.67% | -0.42 -39.13% | |
Diluted EPS and Net Income | -10.63 +1,280.52% | -0.77 +10.00% | -0.70 +66.67% | -0.42 -39.13% | |
Basic Weighted Average Shares | 2.1M -94.59% | 38.8M +7.97% | 35.9M +0.30% | 35.8M +90.84% | |
Diluted Weighted Average Shares | 2.1M -94.59% | 38.8M +7.97% | 35.9M +0.30% | 35.8M +90.84% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.0M -58.23% | 4.7M +30.03% | 3.6M -83.90% | 22.3M +90.32% | |
Short-Term Investments | 0 N/A | N/A N/A | 0 -100.00% | 9.7M -61.03% | |
Cash and Cash Equivalents and Short-Term Investments | 2.0M -58.23% | 4.7M +30.03% | 3.6M -88.79% | 32.1M -12.67% | |
Total Current Assets | 2.3M -59.91% | 5.7M -11.02% | 6.4M -81.20% | 34.1M -15.83% | |
Accumulated Depreciation | 4.2M +13.79% | 3.7M +21.26% | 3.0M +35.52% | 2.2M +35.79% | |
Property and Plant and Equipment and Net | 20.9M -8.86% | 22.9M +12.01% | 20.5M +89.30% | 10.8M +865.48% | |
Total Long-Term Assets | 28,476 0.00% | 28,476 -49.63% | 56,538 -83.07% | 333,875 -15.11% | |
Total Assets | 24.5M -18.91% | 30.2M +6.04% | 28.5M -39.09% | 46.8M -12.53% | |
Income Taxes Payable | 24,897 -39.14% | 40,909 -72.15% | 146,914 N/A | N/A N/A | |
Total Short-Term Debt | 6.8M +7.83% | 6.3M +5,188.77% | 119,398 -99.69% | 38.3M +6,646.39% | |
Total Current Liabilities | 21.1M -28.91% | 29.6M +238.71% | 8.7M +195.88% | 3.0M +27.35% | |
Total Long-Term Debt | 0 -100.00% | 7.4M +17.03% | 6.3M -1.65% | 6.4M N/A | |
Total Long-Term Liabilities | 0 -100.00% | 7.4M +17.03% | 6.3M -1.65% | 6.4M N/A | |
Total Liabilities | 21.8M -41.21% | 37.0M +145.86% | 15.1M +60.46% | 9.4M +304.06% | |
Retained Earnings | -108.5M +7.92% | -100.6M +42.57% | -70.5M +54.89% | -45.5M +48.64% | |
Total Stockholders Equity | 2.8M +140.84% | -6.8M -150.29% | 13.5M -64.03% | 37.4M -26.89% | |
Total Shares Outstanding | 3.3M -92.64% | 44.5M +24.15% | 35.9M 0.00% | 35.9M +737.12% | |
Cash Flow | |||||
Cash from Operating Activities | -13.4M -5.87% | -14.2M -36.81% | -22.5M +116.77% | -10.4M -5.37% | |
Capital Expenditures | 0 -100.00% | 261,617 -95.78% | 6.2M -39.63% | 10.3M +21,640.32% | |
Cash from Investing Activities | 0 +100.00% | -261,617 -106.89% | 3.8M -74.18% | 14.7M +142.00% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 10.7M -31.47% | 15.6M +107,217.90% | -14,534 -100.23% | 6.3M -87.27% | |
Financials Ratio | |||||
Gross Margin | 99.73% +166.82% | 37.38% +89.56% | 19.72% -48.75% | 38.48% N/A | |
Operating Margin | -81.25% -92.93% | -1,148.50% +26.91% | -904.96% +303.43% | -224.32% N/A | |
Return on Assets | -29.07% -71.56% | -102.21% +54.01% | -66.37% +123.41% | -29.71% N/A | |
Return on Equity | 397.45% +144.29% | -897.37% +813.55% | -98.23% +192.11% | -33.63% N/A | |
Revenue Growth | 531.14% +5,588.61% | -9.68% -83.24% | -57.72% -190.26% | 63.95% N/A | |
Current Ratio | 0.11 -43.58% | 0.19 -73.73% | 0.73 -93.65% | 11.52 N/A | |
Cash Ratio | 0.09 -41.25% | 0.16 -61.61% | 0.41 -94.56% | 7.55 N/A | |
Debt-to-Equity Ratio | 2.46 +221.78% | -2.02 -523.83% | 0.48 -60.03% | 1.19 N/A | |
Debt-to-Assets Ratio | 0.28 -38.67% | 0.45 +100.98% | 0.23 -76.40% | 0.95 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow